30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Aditxt Inc (ADTX)

Track

Over the last 90 days, Aditxt Inc. saw 17 insider transactions totaling $82,128.19. While there were net buys, the net value was driven by significant selling activity from HRT FINANCIAL LP and DRW Securities, LLC, alongside notable buying from HRT FINANCIAL LP. The stock has experienced a 100% decline in the past 90 days.
Stock chart
Ticker: ADTX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
DRW Securities, LLC
1 sale — total 100,000 USD
Sale 17 Jun 2026
Value US$3,592,098.52 | Price 481.68 | Shares 3,891
Sale 16 Jun 2026
Value US$2,136,041.99 | Price 440.02 | Shares 25,633
Buy 12 Jun 2026
Value US$100,000.00 | Price 0.02 | Shares 1,000
Sale 11 Jun 2026
Value US$100,000.00 | Price 0.01 | Shares 1,000
Buy 10 Jun 2026
Value US$100,000.00 | Price 0.02 | Shares 1,000
Buy 10 Jun 2026
Value US$100,000.00 | Price 0.02 | Shares 1,000
Buy 10 Jun 2026
Value US$100,000.00 | Price 0.02 | Shares 1,000
Sale 9 Jun 2026
Value US$100,000.00 | Price 0.03 | Shares 1,000
Sale 9 Jun 2026
Value US$100,000.00 | Price 0.03 | Shares 1,000
Sale 9 Jun 2026
Value US$100,000.00 | Price 0.03 | Shares 1,000
Sale 9 Jun 2026
Value US$100,000.00 | Price 0.07 | Shares 1,000
Buy 8 Jun 2026
Value US$100,000.00 | Price 0.05 | Shares 1,000
Sale 5 Jun 2026
Value US$100,000.00 | Price 0.06 | Shares 1,000
Buy 4 Jun 2026
Value US$100,000.00 | Price 0.08 | Shares 1,000
Sale 24 Apr 2026
Value US$8,233.12 | Price 0.28 | Shares 29,404
Sale 23 Apr 2026
Value US$1,105.19 | Price 0.29 | Shares 3,811
Sale 22 Apr 2026
Value US$3,594.60 | Price 0.30 | Shares 11,982
Buy 21 Apr 2026
Value US$24,060.96 | Price 0.33 | Shares 72,912
Sale 25 Nov 2025
Value US$3.20 | Price 3.20 | Shares 1
Sale 16 Oct 2024
Value US$29,874.78 | Price 1.17 | Shares 25,534
Buy 15 Oct 2024
Value US$23,454.00 | Price 1.50 | Shares 15,636
Sale 7 Sep 2023
Value US$691,140.32 | Price 33.23 | Shares 20,800
Buy 19 Jul 2022
Value US$20,000.00 | Price 20,000.00 | Shares 1
Buy 1 Jun 2021
Value US$1,435.70 | Price 2.93 | Shares 490
Buy 1 Jun 2021
Value US$289.00 | Price 2.89 | Shares 100
Buy 1 Jun 2021
Value US$2,320.00 | Price 2.90 | Shares 800
Buy 1 Jun 2021
Value US$2,950.00 | Price 2.95 | Shares 1,000
Buy 1 Jun 2021
Value US$2,950.00 | Price 2.95 | Shares 1,000
Buy 1 Jun 2021
Value US$1,465.00 | Price 2.93 | Shares 500
Buy 1 Jun 2021
Value US$289.00 | Price 2.89 | Shares 100
Buy 1 Jun 2021
Value US$2,320.00 | Price 2.90 | Shares 800
Buy 1 Jun 2021
Value US$2,950.00 | Price 2.95 | Shares 1,000
Buy 1 Jun 2021
Value US$2,950.00 | Price 2.95 | Shares 1,000
Buy 1 Jun 2021
Value US$1,465.00 | Price 2.93 | Shares 500
Buy 1 Jun 2021
Value US$8,819.70 | Price 2.94 | Shares 3,000
Buy 1 Jun 2021
Value US$5,860.00 | Price 2.93 | Shares 2,000
Buy 1 Jun 2021
Value US$5,860.00 | Price 2.93 | Shares 2,000
Buy 1 Jun 2021
Value US$4,688.00 | Price 2.93 | Shares 1,600
Buy 1 Jun 2021
Value US$2,061.08 | Price 2.94 | Shares 700
Buy 1 Jun 2021
Value US$2,054.92 | Price 2.94 | Shares 700
Buy 27 May 2021
Value US$499.50 | Price 2.70 | Shares 185
Buy 26 May 2021
Value US$6,699.75 | Price 2.68 | Shares 2,500
Buy 25 May 2021
Value US$328.44 | Price 2.38 | Shares 138
Buy 25 May 2021
Value US$669.60 | Price 2.40 | Shares 279
Buy 25 May 2021
Value US$10,803.20 | Price 2.56 | Shares 4,220
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-17 S Sale
DRW Securities, LLC
Large shareholder
3,891 +2.6%
481.68
US$3,592,099 		3,891 +2.6% 481.68 US$3,592,099
2026-06-18 2026-06-16 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
25,633 -7.0%
440.02
US$2,136,042 		25,633 -7.0% 440.02 US$2,136,042
2026-06-16 2026-06-12 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
78,250 -21.2%
442.32
US$4,975,147 		78,250 -21.2% 442.32 US$4,975,147
2026-06-12 2026-06-11 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
1,000 -100.0%
0.01
US$100,000 		1,000 -100.0% 0.01 US$100,000
2026-06-11 2026-06-10 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
1,000 +230.5%
0.02
US$100,000 		1,000 +230.5% 0.02 US$100,000
2026-06-11 2026-06-10 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
1,000 +230.5%
0.02
US$100,000 		1,000 +230.5% 0.02 US$100,000
2026-06-11 2026-06-10 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
1,000 +230.5%
0.02
US$100,000 		1,000 +230.5% 0.02 US$100,000
2026-06-11 2026-06-09 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
1,000 -73.6%
0.03
US$100,000 		1,000 -73.6% 0.03 US$100,000
2026-06-11 2026-06-09 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
1,000 -73.6%
0.03
US$100,000 		1,000 -73.6% 0.03 US$100,000
2026-06-11 2026-06-09 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
1,000 -73.6%
0.03
US$100,000 		1,000 -73.6% 0.03 US$100,000
2026-06-10 2026-06-09 S Sale
Gong Sandie
Large shareholder
1,000 -100.0%
0.07
US$100,000 		1,000 -100.0% 0.07 US$100,000
2026-06-11 2026-06-08 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
1,000 +618.5%
0.05
US$100,000 		1,000 +618.5% 0.05 US$100,000
2026-06-08 2026-06-05 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
1,000 -100.0%
0.06
US$100,000 		1,000 -100.0% 0.06 US$100,000
2026-06-08 2026-06-04 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
1,000 +249.4%
0.08
US$100,000 		1,000 +249.4% 0.08 US$100,000
2026-04-27 2026-04-24 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
29,404 -25.0%
0.28
US$8,233 		29,404 -25.0% 0.28 US$8,233
2026-04-27 2026-04-23 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
3,811 -3.1%
0.29
US$1,105 		3,811 -3.1% 0.29 US$1,105
2026-04-23 2026-04-22 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
11,982 -9.0%
0.30
US$3,595 		11,982 -9.0% 0.30 US$3,595
2026-04-23 2026-04-21 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
72,912 +120.2%
0.33
US$24,061 		72,912 +120.2% 0.33 US$24,061
2025-11-26 2025-11-25 S Sale
3.4
Pankovcin Corinne

Chief M&A Officer

Officer
1 -100.0%
3.20
US$3 		1 -100.0% 3.20 US$3
2024-10-17 2024-10-16 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
25,534 -100.0%
1.17
US$29,875 		25,534 -100.0% 1.17 US$29,875
2024-10-17 2024-10-15 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
15,636 +159.6%
1.50
US$23,454 		15,636 +159.6% 1.50 US$23,454
2023-09-07 2023-09-07 S Sale
3.4
BNP PARIBAS SECURITIES CORP

Reduced under 10% owner
20,800 -48.2%
33.23
US$691,140 		20,800 -48.2% 33.23 US$691,140
2022-07-21 2022-07-19 B Purchase
0.6
Albanna Amro A.

Chief Executive Officer

Officer
1 +inf%
20,000.00
US$20,000 		1 +inf% 20,000.00 US$20,000
2021-06-02 2021-06-01 B Purchase
1.4
Shabahang Shahrokh

CHIEF INNOVATION OFFICER

Executive Director
490 +0.0%
2.93
US$1,436 		490 +0.0% 2.93 US$1,436
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Rowena

CHIEF OPERATING OFFICER

Officer
100 +0.0%
2.89
US$289 		100 +0.0% 2.89 US$289
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Rowena

CHIEF OPERATING OFFICER

Officer
800 +0.1%
2.90
US$2,320 		800 +0.1% 2.90 US$2,320
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Rowena

CHIEF OPERATING OFFICER

Officer
1,000 +0.1%
2.95
US$2,950 		1,000 +0.1% 2.95 US$2,950
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Rowena

CHIEF OPERATING OFFICER

Officer
1,000 +0.1%
2.95
US$2,950 		1,000 +0.1% 2.95 US$2,950
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Rowena

CHIEF OPERATING OFFICER

Officer
500 +0.1%
2.93
US$1,465 		500 +0.1% 2.93 US$1,465
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Amro A.

CHIEF EXECUTIVE OFFICER

Executive Director
100 +0.0%
2.89
US$289 		100 +0.0% 2.89 US$289
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Amro A.

CHIEF EXECUTIVE OFFICER

Executive Director
800 +0.1%
2.90
US$2,320 		800 +0.1% 2.90 US$2,320
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Amro A.

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 +0.1%
2.95
US$2,950 		1,000 +0.1% 2.95 US$2,950
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Amro A.

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 +0.1%
2.95
US$2,950 		1,000 +0.1% 2.95 US$2,950
2021-06-02 2021-06-01 B Purchase
0.6
Albanna Amro A.

CHIEF EXECUTIVE OFFICER

Executive Director
500 +0.1%
2.93
US$1,465 		500 +0.1% 2.93 US$1,465
2021-06-02 2021-06-01 B Purchase
0.6
Runge Jeffrey W.
Non-Executive Director
3,000 +31.6%
2.94
US$8,820 		3,000 +31.6% 2.94 US$8,820
2021-06-02 2021-06-01 B Purchase
0.6
Runge Jeffrey W.
Non-Executive Director
2,000 +26.7%
2.93
US$5,860 		2,000 +26.7% 2.93 US$5,860
2021-06-02 2021-06-01 B Purchase
0.6
Runge Jeffrey W.
Non-Executive Director
2,000 +36.4%
2.93
US$5,860 		2,000 +36.4% 2.93 US$5,860
2021-06-02 2021-06-01 B Purchase
0.6
Runge Jeffrey W.
Non-Executive Director
1,600 +41.0%
2.93
US$4,688 		1,600 +41.0% 2.93 US$4,688
2021-06-02 2021-06-01 B Purchase
0.6
Runge Jeffrey W.
Non-Executive Director
700 +21.9%
2.94
US$2,061 		700 +21.9% 2.94 US$2,061
2021-06-02 2021-06-01 B Purchase
0.6
Runge Jeffrey W.
Non-Executive Director
700 +28.0%
2.94
US$2,055 		700 +28.0% 2.94 US$2,055
2021-05-28 2021-05-27 B Purchase
1.4
Shabahang Shahrokh

CHIEF INNOVATION OFFICER

Executive Director
185 +0.0%
2.70
US$500 		185 +0.0% 2.70 US$500
2021-05-27 2021-05-26 B Purchase
1.3
Farley Thomas J

PRINCIPAL ACCOUNTING OFFICER

Officer
2,500 +inf%
2.68
US$6,700 		2,500 +inf% 2.68 US$6,700
2021-05-28 2021-05-25 B Purchase
1.4
Shabahang Shahrokh

CHIEF INNOVATION OFFICER

Executive Director
138 +0.0%
2.38
US$328 		138 +0.0% 2.38 US$328
2021-05-28 2021-05-25 B Purchase
1.4
Shabahang Shahrokh

CHIEF INNOVATION OFFICER

Executive Director
279 +0.0%
2.40
US$670 		279 +0.0% 2.40 US$670
2021-05-25 2021-05-25 B Purchase
3.4
Pankovcin Corinne

CHIEF FINANCIAL OFFICER

Officer
4,220 +3.8%
2.56
US$10,803 		4,220 +3.8% 2.56 US$10,803
Explore more

More insider trading research around Aditxt Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America